Logo

DermTech: DermTech PLAplus

Apr 23, 2021

DermTech has launched its PLAplus test, which adds telomerase reverse transcriptase promoter DNA driver mutation analyses to the firm's current RNA gene expression based Pigmented Lesion Assay (PLA) for early melanoma detection. The firm said the add-on improves the combined tests' sensitivity from 91 percent to 97 percent. 

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.